Alnylam Pharmaceuticals
ALNY
#596
Rank
โ‚น3.937 T
Marketcap
โ‚น29,511
Share price
1.33%
Change (1 day)
45.79%
Change (1 year)
Alnylam Pharmaceuticals Inc. is a biopharmaceutical company focused on the R&D and commercialization of RNA interference (RNAi) therapeutics for genetically defined diseases.

We have found no dividend history for this company